WST Income Statement
West Pharmaceutical Services Inc - Revenue, Expenses & Profit Analysis
Stock Price
$271.83
Market Cap
$19.63B
P/E Ratio
40.5
EPS (TTM)
$6.74
Most Recent Quarter
Period: 2024-12-31(2024-12-31)
Revenue
Total sales from operations
$2.89B
-1.9% YoY
Net Income
Bottom line profit
$492.70M
Margin: 0.2%
Earnings Per Share (Diluted)
Net income per share
$6.69
Profitability Metrics
Gross Margin
35.6%
Operating Margin
0.2%
Net Margin
0.2%
Return on Equity
0.2%
Historical Income Statements
| Period | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2024-12-31 | $2.89B | - | - | $492.70M | $6.69 |
| 2023-12-31 | $2.95B | - | - | $593.40M | $7.88 |
| 2022-12-31 | $2.89B | - | - | $585.90M | $7.73 |
| 2021-12-31 | $2.83B | - | - | $661.80M | $8.67 |
| 2020-12-31 | $2.15B | - | - | $98.40M | $1.29 |
View Complete Financial Analysis
Full income statements, balance sheets, cash flows, and AI-powered insights
Open Full AnalysisFrequently Asked Questions
What is WST's revenue?
WST's most recent quarterly revenue was $2.89B, representing a decline of 1.9% year-over-year.
Is WST profitable?
WST reported a profit of $492.70M in the most recent quarter. The net profit margin is 0.2%.
What is WST's operating income?
Operating income data is available in the income statement.
What is WST's earnings per share (EPS)?
WST reported diluted earnings per share of $6.69 in the most recent quarter.
What is WST's gross profit margin?
WST has a gross profit margin of 35.6%, indicating the profitability of core operations before operating expenses.